These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 19538767

  • 21. The role of urinary NGAL and serum cystatin C in assessing the severity of ureteropelvic junction obstruction in infants.
    Pavlaki A, Printza N, Farmaki E, Stabouli S, Taparkou A, Sterpi M, Dotis J, Papachristou F.
    Pediatr Nephrol; 2020 Jan; 35(1):163-170. PubMed ID: 31606750
    [Abstract] [Full Text] [Related]

  • 22. Epidermal growth factor and monocyte chemotactic peptide-1: potential biomarkers of urinary tract obstruction in children with hydronephrosis.
    Madsen MG, Nørregaard R, Palmfeldt J, Olsen LH, Frøkiær J, Jørgensen TM.
    J Pediatr Urol; 2013 Dec; 9(6 Pt A):838-45. PubMed ID: 23228281
    [Abstract] [Full Text] [Related]

  • 23. Surgical outcomes of laparoscopic dismembered pyeloplasty in children with giant hydronephrosis secondary to ureteropelvic junction obstruction.
    Nerli RB, Reddy MN, Hiremath MB, Shishir D, Patil SM, Guntaka A.
    J Pediatr Urol; 2012 Aug; 8(4):401-4. PubMed ID: 21917524
    [Abstract] [Full Text] [Related]

  • 24. Increased transforming growth factor-beta1 and tubulointerstitial fibrosis in rats with congenital hydronephrosis.
    Zhou Y, Takahashi G, Shinagawa T, Okuhara T, Yonamine K, Aida Y, Tadokoro M.
    Int J Urol; 2002 Sep; 9(9):491-500. PubMed ID: 12410929
    [Abstract] [Full Text] [Related]

  • 25. The roles of serum and urinary carbohydrate antigen 19-9 in the management of patients with antenatal hydronephrosis.
    Atar A, Oktar T, Kucukgergin C, Kalelioglu I, Seckin S, Ander H, Ziylan O, Kadioglu TC.
    J Pediatr Urol; 2015 Jun; 11(3):133.e1-5. PubMed ID: 25824879
    [Abstract] [Full Text] [Related]

  • 26. Equivocal ureteropelvic junction obstruction on diuretic renogram--should minimally invasive pyeloplasty be offered to symptomatic patients?
    Ozayar A, Friedlander JI, Shakir NA, Gahan JC, Cadeddu JA, Morgan MS.
    J Urol; 2015 Apr; 193(4):1278-82. PubMed ID: 25444983
    [Abstract] [Full Text] [Related]

  • 27. Urinary TGF-1 has a supplementary value in predicting renal function recovery post unilateral ureteral obstruction.
    Chen X, Zhu W, Al-Hayek S, Yan X, Jiang C, Zheng X, Guo H.
    Int Urol Nephrol; 2015 Jan; 47(1):33-7. PubMed ID: 25298140
    [Abstract] [Full Text] [Related]

  • 28. Clinical and molecular markers of chronic interstitial nephropathy in congenital unilateral ureteropelvic junction obstruction.
    Murer L, Benetti E, Centi S, Della Vella M, Artifoni L, Capizzi A, Zucchetta P, Del Prete D, Carasi C, Montini G, Rigamonti W, Zaccello G.
    J Urol; 2006 Dec; 176(6 Pt 1):2668-73; discussion 2673. PubMed ID: 17085190
    [Abstract] [Full Text] [Related]

  • 29. Congenital mid ureteral strictures.
    Hwang AH, McAleer IM, Shapiro E, Miller OF, Krous HF, Kaplan GW.
    J Urol; 2005 Nov; 174(5):1999-2002. PubMed ID: 16217377
    [Abstract] [Full Text] [Related]

  • 30. Urinary angiotensinogen as a novel marker of obstructive nephropathy in children.
    Taranta-Janusz K, Wasilewska A, Dębek W, Fiłonowicz R, Michaluk-Skutnik J.
    Acta Paediatr; 2013 Sep; 102(9):e429-33. PubMed ID: 23772991
    [Abstract] [Full Text] [Related]

  • 31. Association of urinary transforming growth factor-β1 with the ureteropelvic junction obstruction.
    Merrikhi A, Bahraminia E.
    Adv Biomed Res; 2014 Sep; 3():123. PubMed ID: 24949294
    [Abstract] [Full Text] [Related]

  • 32. Factors associated with the outcomes of children with unilateral ureteropelvic junction obstruction.
    Chiou YY, Chiu NT, Wang ST, Cheng HL, Tang MJ.
    J Urol; 2004 Jan; 171(1):397-402; discussion 402. PubMed ID: 14665942
    [Abstract] [Full Text] [Related]

  • 33. Renal pelvis cuff pyeloplasty for ureteropelvic junction obstruction for the high inserting ureter: an initial experience.
    Palmer LS, Proano JM, Palmer JS.
    J Urol; 2005 Sep; 174(3):1088-90. PubMed ID: 16094065
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Laparoscopic pyeloplasty for secondary ureteropelvic junction obstruction: long-term results.
    Nishi M, Tsuchida M, Ikeda M, Matsuda D, Iwamura M.
    Int J Urol; 2015 Apr; 22(4):368-71. PubMed ID: 25599801
    [Abstract] [Full Text] [Related]

  • 36. Measurement of urinary TGF-β1 in patients with diabetes mellitus and normal controls.
    Tsapenko MV, Nwoko RE, Borland TM, Voskoboev NV, Pflueger A, Rule AD, Lieske JC.
    Clin Biochem; 2013 Oct; 46(15):1430-5. PubMed ID: 23685222
    [Abstract] [Full Text] [Related]

  • 37. Vesicoureteral reflux and ureteropelvic junction obstruction in children with horseshoe kidney: treatment and outcome.
    Cascio S, Sweeney B, Granata C, Piaggio G, Jasonni V, Puri P.
    J Urol; 2002 Jun; 167(6):2566-8. PubMed ID: 11992090
    [Abstract] [Full Text] [Related]

  • 38. Sonographic biometry in obstructive uropathy of children: preoperative diagnosis and postoperative monitoring.
    Dinkel E, Dittrich M, Peters H, Alzen G, Walz P, Ney C, Schulte-Wissermann H, Weitzel D.
    Urol Radiol; 1985 Jun; 7(1):1-7. PubMed ID: 3885536
    [Abstract] [Full Text] [Related]

  • 39. Urinary extracellular matrix proteins as predictors of the severity of ureteropelvic junction obstruction in children.
    Mello MF, Thalita Dos Reis S, Kondo EY, de Bessa Júnior J, Dénes FT, Lopes RI.
    J Pediatr Urol; 2021 Aug; 17(4):438.e1-438.e7. PubMed ID: 33863647
    [Abstract] [Full Text] [Related]

  • 40. Laparoscopic pyeloplasty for secondary ureteropelvic junction obstruction.
    Sundaram CP, Grubb RL, Rehman J, Yan Y, Chen C, Landman J, McDougall EM, Clayman RV.
    J Urol; 2003 Jun; 169(6):2037-40. PubMed ID: 12771713
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.